ALNA Allena Pharmaceuticals

Allena Pharmaceuticals Inc is a clinical biopharmaceutical company. It focuses on developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders.

$1.25
As of 04/13/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/02/2017
Outstanding shares:  56,938,327
Average volume:  655,657
Market cap:   $71,172,909
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    018119107
ISIN:        US0181191075
Sedol:      BYZ0RD4
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.16
PS ratio:   0.00
Return on equity:   -145.53%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy